Abstract
Background: Gestational diabetes (GDM) is a pregnancy-related endocrinopathy. Its etiology is not well understood. Obesity and insulin resistance coexist in GDM. Apelin is an adipocytokine secreted by fatty cells and expressed in many organs; it can modulate blood glucose. According to research, apelin levels are higher in obese and type 2 diabetes patients. We aimed to examine the value of serum apelin as a reliable marker for GDM at 24-28 weeks of pregnancy.
Methods: A case-control study recruited 120 pregnant women in an age range of 20-40 years with a singleton pregnancy at 24-28 weeks of pregnancy; all were matched in BMI and gestational age. They are divided into 2 groups: 60/120 GDM cases based on the International Association of Diabetes and Pregnancy and 60/120 matched controls at a gestational age of 24-28 weeks at Al-Yarmouk Teaching Hospital. Demographics data, serum biochemical permeates including HbA1c, fasting blood sugar (FBS), fasting insulin level, 1 h plasma glucose, and 2 h plasma glucose, following a 75-gram glucose loading, and a fasting insulin level were recorded.
Results: None of the demographic criteria were significant between the two groups at P < 0.05. FBS, fasting insulin, OGTT-1 and 2 hours, HbA1c, and serum apelin were significantly higher in GDM cases with P < 0.0001. Pearson's correlations show that Apelin has a statistically significant correlation with BMI, FBS, fasting insulin, OGTT-1 and 2 hours, and HbA1c, with r = (0.34, 0.71, 0.65, 0.72, and 0.63) and P < 0.0001. ANOVA confirmed an insignificant effect of BMI centile on serum apelin, P < 0.072. ROC estimated the apelin cut-off at > 11.3 (ng/l), associated with 84% sensitivity and 100% specificity, P < 0.001.
Conclusion: Strong and significant apelin correlations with parameters for screening GDM make it a valuable marker, especially when its levels are unaffected by body mass index. Further studies are recommended to unveil therapeutic avenues for apelin.
Keywords: Gestational diabetes, apelin, screening, blood glucose, glycated hemoglobin, body mass index.
[http://dx.doi.org/10.5812/intjssh.67758]
[http://dx.doi.org/10.1001/jama.2019.4981] [PMID: 31087027]
[http://dx.doi.org/10.29252/aassjournal.7.2.1] [PMID: 31321377]
[http://dx.doi.org/10.3390/ijms19113342] [PMID: 30373146]
[http://dx.doi.org/10.1152/physrev.00063.2017] [PMID: 30067154]
[http://dx.doi.org/10.1155/2021/5325813] [PMID: 34796028]
[http://dx.doi.org/10.1016/j.bpobgyn.2014.09.008] [PMID: 25481558]
[http://dx.doi.org/10.1016/j.atherosclerosis.2019.01.037] [PMID: 30819513]
[http://dx.doi.org/10.1080/17446651.2018.1476135] [PMID: 30063409]
[http://dx.doi.org/10.1016/j.cytogfr.2019.03.003] [PMID: 30910349]
[http://dx.doi.org/10.3389/fphys.2018.00557] [PMID: 29875677]
[http://dx.doi.org/10.4103/japtr.JAPTR_273_18] [PMID: 30338233]
[http://dx.doi.org/10.1007/s40618-018-0973-2] [PMID: 30392100]
[http://dx.doi.org/10.1002/jcp.30845] [PMID: 35933701]
[http://dx.doi.org/10.2337/dc14-0179] [PMID: 24947793]
[http://dx.doi.org/10.1080/09513590.2020.1739264] [PMID: 32208782]
[http://dx.doi.org/10.1007/s12020-011-9577-8] [PMID: 22203468]
[http://dx.doi.org/10.3109/01443615.2015.1103716] [PMID: 26759187]
[http://dx.doi.org/10.1530/EJE-08-0039] [PMID: 18390990]
[http://dx.doi.org/10.1016/j.metabol.2018.11.008] [PMID: 30468781]
[http://dx.doi.org/10.1371/journal.pone.0202350] [PMID: 30157220]
[http://dx.doi.org/10.1007/s11695-009-9955-y] [PMID: 19756893]
[http://dx.doi.org/10.2174/1573404817666211208152049]
[http://dx.doi.org/10.1016/j.lfs.2020.118310] [PMID: 32835696]
[http://dx.doi.org/10.1155/2021/5547228] [PMID: 34212049]
[http://dx.doi.org/10.1111/j.1365-2265.2011.04061.x] [PMID: 21521329]
[http://dx.doi.org/10.1186/s12944-020-01209-7] [PMID: 32087711]
[http://dx.doi.org/10.1080/09513590.2019.1597346] [PMID: 30990092]
[http://dx.doi.org/10.1016/j.cmet.2008.10.003] [PMID: 19046574]
[http://dx.doi.org/10.1016/j.tem.2012.02.005] [PMID: 22445464]
[http://dx.doi.org/10.3390/cells11010099] [PMID: 35011661]
[http://dx.doi.org/10.12659/AJCR.932722] [PMID: 34615846]
[http://dx.doi.org/10.1080/09513590.2016.1254613] [PMID: 27910708]
[http://dx.doi.org/10.1016/j.rbmo.2011.10.011] [PMID: 22197604]
[http://dx.doi.org/10.1016/j.ejogrb.2012.03.003] [PMID: 22464209]
![Wayfinder Image](/images/wayfinder.jpg)